American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on April 26, 2025

AgencyPlatform Launches Updated AI-Focused SEO Deliverables for 2025

AgencyPlatform Launches Updated AI-Focused SEO Deliverables for 2025

Elevate your SEO game: AgencyPlatform's AI-focused deliverables for 2025 provide agencies with advanced optimization capabilities. MANHATTAN, NY, UNITED STATES, April 26, 2025 /⁨EINPresswire.com⁩/ -- Manhattan, NY, April 24, 2025: In response to a …

Fambase Introduces Private Mode for Group Fitness, Addressing Concerns Over Online Visibility

Fambase Introduces Private Mode for Group Fitness, Addressing Concerns Over Online Visibility

As more individuals seek low-visibility spaces for online learning, a quiet but deliberate shift is taking place. LOS ANGELES, CA, UNITED STATES, April 26, 2025 /⁨EINPresswire.com⁩/ -- Fambase, a leading platform for private group-based online interaction …

TurboTenant VP Talks Property Management Software on Xraised

TurboTenant VP Talks Property Management Software on Xraised

DENVER, CO, UNITED STATES, April 26, 2025 /⁨EINPresswire.com⁩/ -- TurboTenant has quickly become one of the most popular property management software solutions for landlords. What makes it stand out in a crowded market is its freemium model, which offers …

Glucovy Reviews (Customer Complaints Investigated) Does This Gluco Control Supplement Really Work?

Glucovy Reviews (Customer Complaints Investigated) Does This Gluco Control Supplement Really Work?

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- For anyone pursuing better health—whether it’s sustained energy, improved focus, or weight management, balanced blood sugar is often the hidden key. Yet, in today’s fast-paced lifestyle filled with stress, …

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co-founders, Mads …

These 5 AI trends Will Shape 2025, Says New Report

These 5 AI trends Will Shape 2025, Says New Report

SAN JUAN, Puerto Rico, April 26, 2025 (GLOBE NEWSWIRE) -- A recent analysis from GreenBot breaks down the top five AI trends that are already transforming how we interact with technology in 2025. As artificial intelligence continues to blend into the tools …

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting

GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV administration. Significant tumor reduction was observed in both administration routes. Both IT and IV were well-tolerated and demonstrated enhanced IFN-γ expression in …

A.I.S. Resources Closes Non-Brokered Private Placement

A.I.S. Resources Closes Non-Brokered Private Placement

VANCOUVER, British Columbia, April 25, 2025 (GLOBE NEWSWIRE) -- A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces the Company has closed its non-brokered private placement of 1,232,417 units (“Units”) at a price of $ …

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service